![]() ![]() Concerns about the employment outlook and global political uncertainties could also contribute to increased selling. Many still subscribe to the old "sell in May and go away" school of thought. That's more likely as we approach summer. So what is the most likely impediment to Johnson & Johnson stock success? The answer: Its continued stock success.Īfter a great start to 2013 and a gain of 27% over the last 12 months, some investors could be ready to take some profits. In late March, J&J announced that it was pulling nearly 2 million glucose meters from the market after a patient in Europe died following a faulty blood sugar reading. Shares continued their upward path even after this recall announcement. However, the company's latest recall doesn't seem to have fazed the stock. Johnson & Johnson stock took a hit in 2010 and early 2011 partially due to recalls of several products. Covidien's ( COV.DL) shares were temporarily affected by the company's recall of surgical tools last year. The largest business segment, medical devices and diagnostics, generated $27.4 billion in 2012 revenue. Its consumer segment brought in $14.4 billion in sales last year. J&J's pharmaceuticals segment made $25.3 billion, with the biggest-selling drug, Remicade, accounting for only $6.1 billion of that total. The company's revenue is spread across three large operating segments. J&J's diversification prevents that type of problem from raising its ugly head. Although sales for the blockbuster drug continue to experience solid growth, any blip would send AbbVie's shares headed downward. AbbVie ( ABBV 2.25%) is highly dependent on the success of one drug - Humira. There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson. But could there be a roadblock ahead that will put a damper on these steady gains? The chart definitely shows a good run for J&J. ![]() Shares in the blue-chip company are up 15% year-to-date with a nice upward trend. So, a turnaround in policy - and therefore, in sentiment - may be in store at some point for QuantumScape and its shareholders.If you're looking for a textbook example of a steady rise in shares, it doesn't get much better than the current Johnson & Johnson ( JNJ 0.47%) stock run-up. Manchin “has not walked away from the table,” which seems to suggest that negotiations are ongoing. In contrast, Plug Power (NASDAQ: PLUG), FuelCell Energy (NASDAQ: FCEL) and Bloom Energy (NYSE: BE) stocks fell much further.īesides, Runyon offered a glimmer of hope for supporters of Biden’s spending package. The QuantumScape share price only pulled back moderately in morning trading. Still, it could be said that QS stock is holding up comparatively well today. And by thistime, he figured, the law wanted. Hence, QuantumScape’s investors are happy when the government supports clean energy spending, and disappointed when that spending gets held up by political wrangling. radio ahead and have a roadblock waiting for him if they wanted him bad enough, so it was best to go to ground. QuantumScape produces solid-state batteries, which are mainly designed to be used in electric vehicles (EVs). It appears, then, that traders are connecting the dots between Biden’s stalled climate agenda and QuantumScape’s business model. Consequently, Manchin’s vote - and, by extension, his influence over other senators - is of critical importance. Senate is evenly divided between Democrats and Republicans. Why does one politician’s opinion matter so much? It’s because currently, the U.S. Manchin, emphasized that the senator wishes to “avoid taking steps that add fuel to the inflation fire.” Yesterday, Manchin made it clear that he doesn’t support federal funding for Biden’s climate or energy programs, at least in their current form. Joseph Manchin seems to have put up a roadblock to Biden’s plans. This would undoubtedly involve federal spending on climate change initiatives. ![]() carbon emissions by around 50% by the end of this decade. It’s no secret that Biden seeks to reduce U.S. Mostly likely, QS stock is having trouble staying above water today due to political wrangling over President Joseph Biden’s plans for the U.S. Today, investors seem to be undecided regarding solid-state lithium battery maker QuantumScape (NYSE: QS). InvestorPlace - Stock Market News, Stock Advice & Trading Tips ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |